Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thiamine + promethazine is a combination drug consisting of thiamine (vitamin B1) and promethazine. Thiamine is an essential water-soluble vitamin involved in carbohydrate metabolism and neural function, while promethazine is a first-generation antihistamine of the phenothiazine class with strong sedative, antiemetic, anticholinergic, and antihistaminic properties. Promethazine acts primarily as an antagonist at the histamine H1 receptor but also blocks muscarinic acetylcholine receptors, alpha-adrenergic receptors, serotonin 5-HT2A/2C receptors, dopamine D2 receptors (weakly), and NMDA receptors. The combination may be used in clinical settings where both prevention/treatment of nausea or allergic symptoms (promethazine) and supplementation or treatment/prevention of thiamine deficiency (thiamine) are required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thiamine + promethazine.